HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

WW

WW International, Inc.

Healthcare — Medical Care Facilities

WW International, Inc. provides weight management products and services in the United States, Germany, Canada, and internationally. It offers various nutritional, activity, behavioral, and lifestyle tools and approaches for individual weight goals, as well as for people taking GLP-1 medications or living with diabetes, as well as offers guidance and medication access for women reaching perimenopause and menopause. The company also provides Core, a digital subscription product for weight loss and weight management; Core+ tier, a subscription for unlimited access to workshops; and Med+ subscription tier provides unlimited access to a clinician who can prescribe medications when clinically appropriate, including oral and injectable GLP 1s and hormone replacement therapy. In addition, it licenses its trademarks and other intellectual property in food, beverages, and other weight management-relevant consumer products and services, as well as provides publishing services. The company was formerly known as Weight Watchers International, Inc. and changed its name to WW International, Inc. in September 2019. WW International, Inc. was founded in 1963 and is headquartered in New York, New York.

None 3 analysts
$13.72
$-1.74 (-11.25%)
Target: $28.33 (106.5%)

Price History

52-Week Range
Sign in to add WW to a watchlist or set price alerts.

Fundamentals

Market Cap$143.58M
P/E Ratio (TTM)1.63
Forward P/E-107.70
EPS (TTM)$8.81
Dividend Yield-
Profit Margin155.50%
Revenue Growth-9.80%
ROE-
Debt/Equity176.30
Recommendation None
Analyst Target$28.33
Analysts3
Next Earnings Aug 5, 2026 AMC
Indexes -

Technical Indicators

RSI (14)48.4
Beta-
SMA 20$14.64
SMA 40$16.14
52-Week High$45.00
52-Week Low$8.37
50-Day Avg$15.80
200-Day Avg$20.35
Avg Volume238.9K
Volume81.1K

Performance Analysis

NEUTRAL

WW presents a mixed picture with both positive and negative indicators.

~ Trading at 15% of its 52-week range.
~ RSI at 48.4 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
+ P/E of 1.6 suggests the stock may be undervalued.
- Revenue declined 9.8% year-over-year.
+ Healthy profit margin of 155.5%.
~ Wall Street consensus is "none" from 3 analysts.
+ Average analyst target of $28.33 implies 106.5% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Aug 01, 2026 04:13 UTC

Back to Screener Export Report